Fundz

Outpace Bio

Seattle, Washington, United States · Biotechnology · 200 employees

Outpace is creating cell therapies with curative potential through protein design and cellular engineering. With an initial focus on solid tumors, Outpace is developing technologies that overcome the barriers to efficacy and safety by programming cells to make the right decisions inside patients. Outpace’s suite of technologies drive persistent activity of the cell therapy (OutLast™), recruit a pr

Funding history

  • Funding Round — $56.0M — Aug 2024

Recent signals

  • Nov 05, 2024: Launched Outpace Bio unveils new data on CAR T cell candidate OPB-101 at the SITC Annual Meeting to enhance efficacy against solid tumors.
  • Aug 01, 2024: Raised $56.0M

See plans & pricing → Track Outpace Bio’s funding, hiring, and signals — with verified contacts — on Fundz.